Skip to content
IGM Biosciences
About Us
Our Company
Leadership Team
IGM Platform
Our IGM Platform
Publications
Presentations
Pipeline & Programs
Pipeline
Imvotamab
IGM-2644
Investors & News
Join Us
Our Culture
Open Jobs
Contact Us
<
Back to Presentations
November 2021
Multimeric IgM Antibodies Targeting DR5 are Potent and Rapid Inducers of Tumor Cell Apoptosis In Vitro and In Vivo
PEGS Europe – November 4, 2021
View Presentation